Overview

Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia

Status:
Withdrawn

Trial end date:
2020-09-01

Target enrollment:

Participant gender:

Summary

The study evaluates whether the use of Sodium Oxybate (Xyrem®) in TBI patients will be effective in reducing symptoms of post traumatic narcolepsy and post traumatic hypersomnia.

Phase:

Early Phase 1

Details

Lead Sponsor:

Brigham and Women's Hospital

Treatments:

Pharmaceutical Solutions
Sodium Oxybate